Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
Titel:
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
Auteur:
Naeem, Aishath Utro, Filippo Wang, Qing Cha, Justin Vihinen, Mauno Martindale, Stephen Zhou, Yinglu Ren, Yue Tyekucheva, Svitlana Kim, Annette S. Fernandes, Stacey M. Saksena, Gordon Rhrissorrakrai, Kahn Levovitz, Chaya Danysh, Brian P. Slowik, Kara Jacobs, Raquel A. Davids, Matthew S. Lederer, James A. Zain, Rula Smith, C. I. Edvard Leshchiner, Ignaty Parida, Laxmi Getz, Gad Brown, Jennifer R.